HCV-associated mixed cryoglobulinemia and b-cell non-Hodgkin's lymphoma - pathogenetically related problems
- Authors: Milovanova SY.1, Lysenko (Kozlovskaya) LV1, Milovanova LY.1, Mrykhin NN1, Russkih AV2, Muchin NA1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical Univesity, Ministry Health of Russia (Sechenov University)
- Clinical Hospital of Moscow Department of Ministry of Internal Affairs of the Russian Federation Health care Unit
- Issue: Vol 90, No 6 (2018)
- Pages: 112-120
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32807
- DOI: https://doi.org/10.26442/terarkh2018906112-120
- ID: 32807
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
S Yu Milovanova
I.M. Sechenov First Moscow State Medical Univesity, Ministry Health of Russia (Sechenov University)
Email: sveta@milovanova.ru
д.м.н., в.н.с. НИО здоровьесберегающих технологий Научно-технологического парка биомедицины Первого МГМУ им. И.М. Сеченова Moscow, Russia
L V Lysenko (Kozlovskaya)
I.M. Sechenov First Moscow State Medical Univesity, Ministry Health of Russia (Sechenov University)проф. каф. внутренних, профессиональных болезней и ревматологии медико-профилактического факультета Первого МГМУ им. И.М. Сеченова Moscow, Russia
L Yu Milovanova
I.M. Sechenov First Moscow State Medical Univesity, Ministry Health of Russia (Sechenov University)д.м.н., доц. каф. внутренних, профессиональных болезней и ревматологии медико-профилактического факультета Первого МГМУ им. И.М. Сеченова Moscow, Russia
N N Mrykhin
I.M. Sechenov First Moscow State Medical Univesity, Ministry Health of Russia (Sechenov University)зав. лаб. Университетской клинической больницы (УКБ) № 3 Первого МГМУ им. И.М. Сеченова Moscow, Russia
A V Russkih
Clinical Hospital of Moscow Department of Ministry of Internal Affairs of the Russian Federation Health care Unitд.м.н., зам. начальника Клинического госпиталя ФКУЗ «Медико-санитарная часть МВД России по г. Москве» Moscow, Russia
N A Muchin
I.M. Sechenov First Moscow State Medical Univesity, Ministry Health of Russia (Sechenov University)д.м.н., проф., акад. РАН, зав. каф. внутренних, профессиональных болезней и ревматологии медико-профилактического факультета МГМУ им. И.М. Сеченова Moscow, Russia
References
- Shultz D.R, Yunis A.A. Immunoblastic lymphadenopathy with mixed cryoglobulinemia. A detailed case study. N Engl J Med. 1975 Jan 2; 292(1):8-12.
- Monteverde A, Rivano M.T, Allegra G.C, et al. Essential mixed cryoglobulinemia, type II: a manifestation of a low grade malignant lymphoma? Clinical morphological study of 12 cases with special reference to immunohistoclinical findings in liver frozen section. Acta Haematol. 1988;79:20-5.
- Monteverde A, Ballare M, Pileris S. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin Immunopathol. 1997;19:99-110.
- Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: A meta - analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2006;15:2078-85.
- De Sanjose S, Benavente Y, Vajdic C.M, Engels E.A, Morton L.M, et al. Hepatitis C and non - Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol. 2008;6:451-8.
- Giordano T.P, Henderson L, Langren O. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA. 2007;18:2010-7.
- Gisbert J.P, Garcia-Buey L, Arranz R, Blas C, Pinilla I, Khorrami S, et al. The prevalence of hepatitis C virus infection in patients with non-Hodgkins lymphoma. Eur J Gastroenterol Hepatol. 2004; 16:135-8.
- Gisbert J.P, Garcia-Buey L, Pajares J.M, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkins lymphoma: systematic review and meta - analysis. Gastroenterology. 2003;125:1723-32.
- Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller N.E. Effect of hepatitis C virus infection on the risk of non - hodgkins lymphoma: A meta - analysis of epidemiological studies. Cancer Sci. 2004; 95:745-52.
- Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case - control study. Blood. 2003;102:996-9.
- Monti G, Pioltelli P, Saccardo F, Campanini M, Candela M, et al. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case of patients with hepatitis C virus - related symptomatic mixed cryoglobulinemia. Arch Intern Med. 2005;165:101-5.
- Pozzato G, Mazzaro C, Crovatto M, Modolo M.L, Ceselli S, Mazzi G, et al. Low - grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood. 1994; 84: 3047-53.
- Talamini R, Montella M, Crovatto M, Dal Maso Crispo A, Negri E, et al. Non - hodgkins lymphoma and hepatitis C virus: A case - control study from northern and southern Italy. Int J Cancer. 2004;110:380-5.
- Collier J.D, Zanke B, Moore M, Kessler G, Krajden M, Shepherd F, et al. No association between hepatitis C and B-cell lymphoma. Hepatology. 1999;29:1259-61.
- Ferri C, Sebastiani M, Giuggioli D, Colaci M, Antonelli A, Zignego A.L. Hepatitis C virus syndrome: A constellation of organ - and non - organ specific autoimmune disorders, B-cell non-Hodgkins lymphoma, and cancer. W J Hepatol. 2015;7(3):327-43.
- Nieters A, Kallinowski B, Brennan P, Ott M, et al. Hepatitis c virus and risk of lymphoma:results of the European multicenter case - control study EPILYMPH. Gastroenterology. 2006; 131: 1879-86.
- Лепков В., Сторожаков Г.И., Косюра С.Д. и др. Хронический вирусный гепатит С и лимфопролиферативные заболевания. Современная онкология. 2006;(2):57-60.
- Sung V.M, Shimodaira S, Doughty A.L, Picchio G.R, Can H, Yen T.S, et al. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol. 2003;77:2134-46.
- Lanford R.E, Chavez D, Chisari F.V, Sureau C. Lack of detection of negative - strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand - specific rTth reverse transcriptase PCR. J Virol. 1995;69:8079-83.
- Lerat H, Berby F, Trabaud M.A, Vidalin O, Major M, Trepo C, et al. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest. 1996;97:845-51.
- Peveling-Oberhag J, Arcani L, Yasmann M-L, Zeuzem S. Hepatitis C-associated B-cell non-Hodgkin Lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol. 2013;59:169-77.
- Allander T, Drakenberg K, Beyene A, Rosa D, Abrignani S, Houghton M, et al. Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81. J Gen Virol. 2000;81:2451-9.
- Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, et al. Binding of hepatitis C virus to CD81. Science. 1998;282:938-41.
- Zuckerman E, Slobodin G, Kessel A, Sabo E, Yeshurun D, Halas K, et al. Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection. Clin Exp Immunol. 2002;128:353-8.
- Carter R.H, Fearon D.T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science. 1992;256:105-7.
- Matsumoto A.K, Martin D.R, Carter R.H, Klickstein L.B, Ahearn J.M, Fearon D.T. Functional dissection of the CD21/CD19/Leu-13 complex of B lymphocytes. J Exp Med. 1993;178:1407-17.
- Rosa D, Saletti G, de Gregorio E, Zorat F, Comar C, et al. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus - associated B lymphocyte disorders. Proc Natl Acad Sci USA. 2005;102:18544-9.
- Tursi A, Brandimarte G, Torello M. Disappearance of gastric mucosa - associated lymphoid tissue in hepatitis C virus - positive patients after anti - hepatitis C virus therapy. J Clin Gastroenterol. 2004; 38: 360-3.
- Cacoub P, Renou C, Kerr G, Hue S, Rosenthal E, et al. Influence of HLA-DR phenotype on the risk of hepatitis C virus - associated mixed cryoglobulinemia. Arthritis Rheum. 2001;44:2118-24.
- Charles E.D, Dustin L.B. Hepatitis C virus induced cryoglobulinemia. Kidney Int. 2009; 76(8): 818-24.
- De Re V, Caggiari L, Monti G, Libra M, Spina M, et al. HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkins lymphoma is related to the type II mixed cryoglobulinemia. Tissue Antigens. 2010;75:127-35.
- Игнатова Т.М., Милованова С.Ю., Чернова О.А. В-лимфома у больной хроническим гепатитом С и смешанной криоглобулинемией II типа. Терапевтический архив. 2011;3(4):69-71.
- Милованова С.Ю., Игнатова Т.М., Козловская Л.В. Особенности течения хронического гепатита С с криоглобулинемией. Клиническая гепатология. 2006;2(1):15-8.
- Agnello V, Zhang Q.X, Abel G, Knight G.B. The association of hepatitis C virus infection with monoclonal rheumatoid factors bearing the WA cross - idiottype: implications for the etiopathogenesis and therapy of mixed cryoglobulinemia. Clin Exp Rheumatol. 1995;13:S101-4.
- Chan C.H, Hadlock K.G, Foung S.K, Levy S. V(H)1-69 gene is preferentially used by hepatitis c virus - associated B-cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood. 2001; 97:1023-6.
- Conca P, Tarantino G. Hepatitis C virus lymphotropism and peculiar immunological phenotype: effect on natural history and antiviral therapy. World J Gastroenterol. 2009;15:2305-8.
- Agnello V, Chung R.T, Kaplan L.M. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992;327:1490-5.
- Fabris M, Quartuccio L, Sacco S, de Marchi G, Pozzato G, Mazzaro C, et al. B-Lymphocyte stimulator (BlyS) up - regulation in mixed cryoglobulinemia syndrome and hepatitis C virus infection. Rheumatology. 2007;46:37-43.
- Kitay-Cohen Y, Amiel A, Hilzenrat N, Buskila D, Ashur Y, Fejgin M, et al. Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood. 2000; 96:2910-2.
- Libra M, Gloghini A, Malaponte G, Gangemi P, de Re V, Cacopardo B, et al. Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas. J Hepatol. 2008;49:170-4.
- Zignego A.L, Giannelli F, Marrocchi M.E, Mazzocca A, Ferri C, Giannini C, et al. T(14;18) translocation in chronic hepatitis C virus infection. Hepalology. 2000;31:474-9.
- Милованова С.Ю. Смешанная криоглобулинемия, ассоциированная с хроническим гепатитом С: значение в развитии внепеченочных проявлений, методы лечения. Автореф. дисс. … докт. мед наук. Москва; 2013.
- Sanjose S, Nieters A, Goedert J.J, et al. Role of hepatitis C virus infection in malignant lymphoma in Spain. Int J Cancer. 2005 Aug 10;111(1):81-5.
- Zignego A.L, Macchina D, Monti M, et al. Infection of peripheral mononuclear cells by hepatitis C virus. J Hepatol. 1992;15:382-6.
- Zuckerman E, Zuckerman T, Sahar D, et al. Bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br J Haematol. 2001;112(2):364.
- Клинические рекомендации по диагностике и лечению неходжкинских лимфом у больных, инфицированных вирусами гепатита В и С. Национальное гематологическое общество, Российское профессиональное общество онкогематологов. 2014.
- Hermine O, Lefrere F, Bronowicki J.P, Mariette X, Jondeu K, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002; 347:89-94.
- Kelaidi C, Rollot F, Park S, Tulliez M, Christoforov B, et al. Response to antiviral treatment in hepatitis C virus - associated marginal zone lymphomas. Leukemia. 2004;18:1711-6.
- Mazzaro C, de Re V, Spina M, Dal Maso L, Festini G, Comar C, et al. Pegylated - interferon plus ribavirin for HCV positive indolent non-Hodgkin lymphomas. Br J Haematol. 2009;145:255-7.
- Vallisa D, Bernuzzi P, Arcaini L, Sacchi S, Callea V, Marasca R, et al. Role of anti - hepatitis C virus (HCV) treatment in HCV-related, low - grade, B-cell, non-Hodgkins lymphomas: a multicenter Italian experience. J Clin Oncol. 2005;23:468-73.
- Arcaini L, Vallisa D, Rattotti S, et al. Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi. Ann Oncol. 2014;25(7):1404-10.
- Michot J.M, Canioni D, Driss H, Alric L, Cacoub P, et al. Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell Non-Hodgkin lymphomas, ANRS Hc-13 lympho-C study. Am J Hematol. 2015;90(3):197-203.
- Carrier P, Jaccard A, Tabouret T, Debette-Gratien M, Abraham J, et al. HCV-associated B-cell non-Hodgkin Lymphomas and new direct antiviral agents. Liver Int. 2015;35:2222-7.
- Sultanik P, Klotz C, Brault P, Pol S, Mallet V. Regression of an HCV-associated disseminated marginal zone lymphoma under INF-free treatment. Blood. 2015;125:2446-7.
- Rossotti R, et al. Hodgkin lymphomas and new direct antiviral agents. Liver Int. 2015; l.35(10): 125-32.
- Lim S, Wykeret B, Bartley K, Eisenhower D.Measurement Error and Physical Activity. Am J Epidemiol. 2015;181(9):659-60. doi: 10.1093/aje/kwu473
- Romagnoli D, Marrazzo A, Ballestri S, et al. Sofosbuvir - based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma. J Clin Virol. 2015;69:74-7.
![](/img/style/loading.gif)